Here is the latest shareholding Pattern of BHANSALI ENG. For more details, see the BHANSALI ENG financial fact sheet and BHANSALI ENG share price.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 56.64 | 56.64 | 56.64 | 56.71 | 57.47 | 57.47 | 57.47 | 57.47 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 56.64 | 56.64 | 56.64 | 56.71 | 57.47 | 57.47 | 57.47 | 57.47 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.05 | 0.06 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.89 | 0.82 | 0.85 | 0.93 | 1.03 | 0.95 | 1.13 | 1.12 | |
Other | % | 0.02 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.00 | |
Total Institution | % | 0.91 | 0.82 | 0.85 | 0.93 | 1.02 | 0.99 | 1.17 | 1.18 | |
Bodies Corporate | % | 3.64 | 3.65 | 3.62 | 3.37 | 3.44 | 4.09 | 4.28 | 4.06 | |
Individuals | % | 33.25 | 30.62 | 30.62 | 30.86 | 30.24 | 29.90 | 29.61 | 29.82 | |
NRIs/OCBs | % | 1.05 | 1.04 | 1.02 | 1.01 | 1.19 | 0.98 | 0.93 | 0.93 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 4.50 | 7.22 | 7.24 | 7.12 | 6.63 | 6.57 | 6.53 | 6.54 | |
Total Non-Institution | % | 42.44 | 42.53 | 42.50 | 42.36 | 41.50 | 41.54 | 41.35 | 41.35 | |
Total Public | % | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Chemicals & Pesticides Company Shareholding Pattern: VIKAS LIFECARE STYRENIX PERFORMANCE MANALI PETRO SUPREME PETR NOCIL
Asian share benchmarks fell on Thursday as markets digested the implications of policymakers in major economies preferring to take patient approach to monetary easing amid sticky inflation.